by Reuters | Apr 21, 2021 | Business, Europe, Health, UK
By Carl O’Donnell and Julie Steenhuysen (Reuters) – A U.S. plant that was making Johnson & Johnson’s COVID-19 vaccine must fix a long list of problems including peeling paint, shoddy cleanups, and poorly-trained staff to resume operation,...
by Reuters | Apr 21, 2021 | Business, Economy, Environment, Health, Politics, US
WASHINGTON (Reuters) – U.S. Treasury Secretary Janet Yellen said on Wednesday that companies setting ambitious carbon reduction targets are already helping financial institutions manage climate-related risks and helping support a transition to a low-carbon...
by Reuters | Apr 21, 2021 | Asia, Business, Europe, Health, Technology, UK, US
By Nick Carey, Paul Lienert and Tina Bellon LONDON (Reuters) – Britain’s goal to be a leader in adopting self-driving cars could backfire unless automakers and government regulators spell out the current limitations of the technology, insurance companies...
by Reuters | Apr 21, 2021 | Business, Europe, Health
By John Miller ZURICH (Reuters) – Swiss drugmaker Roche predicted on Wednesday that demand for its drugs would accelerate for the remainder of 2021, after first-quarter sales of COVID-19 tests offset a pandemic-influenced slump in its main pharmaceuticals...
by Reuters | Apr 20, 2021 | Business, Health
By Manas Mishra and Carl O’Donnell (Reuters) -Johnson & Johnson said on Tuesday it will resume rolling out its COVID-19 vaccine in Europe after the region’s medical regulator said the benefits of the shot outweigh the risk of very rare, potentially...
by Reuters | Apr 20, 2021 | Business, Health, US
(Reuters) -Abbott Laboratories fell short of first-quarter revenue estimates on Tuesday due to easing demand for some of its COVID-19 tests, stoking fears of slowing growth for the business as vaccinations gain steam across the globe. The company’s shares fell...
